Search Results 1861-1870 of 17299 for magnesiummagnesium

1. Chemotherapy Combined With Immunotherapy vs Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial - Mayo Clinic

   exceed the equivalent of prednisone 10 mg daily). Short courses of steroids which are discontinued prior to randomization are acceptable. Patients on ...

2. Ablation-Index Guided Scar-Mediated Ventricular Tachycardia Ablation in Patients With Ischemic Cardiomyopathy (AIM-VT) - Mayo Clinic

   Ezio; Bongiorni MG. Maria Grazia; Della Rocca DG. Domenico Giovanni; Mohanty S. Sanghamitra; Carbucicchio C. Corrado; Duru F. Firat; Di Biase L. Luigi ...

3. Bicalutamide With or Without Akt Inhibitor MK2206 in Treating Patients With Previously Treated Prostate Cancer - Mayo Clinic

   ... mg per day is allowed. Patients with impaired cardiac function including any one of the following will be excluded from entry on study: Baseline corrected QT ...

4. Phase 2 Efficacy, Safety, and Tolerability Study of Natalizumab in Focal Epilepsy - Mayo Clinic

   The purpose of this study is to determine if adjunctive therapy of natalizumab 300 mg intravenous (IV) every 4 weeks reduces the frequency of seizures in adult ...

5. A Study to Test How Effective and Safe GLPG1690 is for Subjects With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard Medical Treatment - Mayo Clinic

   ... mg/day or equivalent. Current alcohol or substance abuse in the opinion of the investigator. Pregnant, breastfeeding, or planning to become pregnant or ...

6. A Study to Evaluate the Effectiveness, Safety, Pharmacokinetics and Pharmacodynamics of Idasanutlin Monotherapy in Participants With Hydroxyurea-Resistant/Intolerant Polycythemia Vera - Mayo Clinic

   Serum total bilirubin < 2 mg/dL, unless resulting from hemolysis or known Gilbert's disease. AST/ALT < 2.5 x institutional ULN. Adequate renal function ...

7. Health Topics - Mayo Clinic News Network

   ROCHESTER, Minn. — Mayo Clinic Comprehensive Cancer Center researchers will present their latest radiation oncology findings at the 2025 American Society for ...

8. A Study of Adjuvant Pembrolizumab/Vibostolimab (MK-7684A) Versus Pembrolizumab for Resected High-Risk Melanoma in Participants With High-Risk Stage II-IV Melanoma (MK-7684A-010/KEYVIBE-010) - Mayo Clinic

   (in dosing exceeding 10 mg daily of prednisone equivalent) or any other form of immunosuppressive therapy within 7 days prior the first dose of study ...

9. Study of Cabozantinib Combined With Atezolizumab Vs. Second Novel Hormonal Therapy in Subjects with Metastatic Castration-Resistant Prostate Cancer - Mayo Clinic

   Systematic treatment with, or any condition requiring, either corticosteroids (>10 mg daily prednisone equivalent) or other immunosuppressive medications ...

10. A Study of HFB200301 in Adult Patients With Advanced Solid Tumors - Mayo Clinic

    - Systemic steroid therapy (>10 mg/day of prednisone or equivalent) or any immune suppressive therapy - Persisting toxicity of ≥Grade 2 (≥Grade 1 for ...